Mirum Pharmaceuticals, Inc. SEC filings MIRM
Mirum Pharmaceuticals, Inc. has 674 filings in SEC EDGAR's recent list, going back to Nov 20, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Other events
|
Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Other events
|
Oct 13, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 8, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
May 18, 2026 | May 12, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Other events
|
May 4, 2026 | May 4, 2026 |
| 8-K |
Current report
Other events
|
Apr 27, 2026 | Apr 27, 2026 |
| 8-K/A | Amended current report | Apr 8, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure, Other events
|
Jan 26, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Dec 19, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 19, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Dec 8, 2025 | Dec 6, 2025 |
| 8-K |
Current report
Other events
|
Nov 17, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2025 | May 29, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Other events
|
Jun 17, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Other events
|
May 31, 2024 | May 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 16, 2024 | Jan 11, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Other events
|
Dec 18, 2023 | Dec 18, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K/A | Amended current report | Nov 2, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Other events
|
Oct 17, 2023 | Oct 17, 2023 |
| 8-K |
Current report
Other events
|
Oct 13, 2023 | Oct 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Sep 5, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2023 | Aug 24, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 17, 2023 | Jul 16, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Apr 17, 2023 | Apr 12, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Apr 12, 2023 | Apr 12, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 6, 2023 | Apr 5, 2023 |
| 8-K |
Current report
Other events
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2023 | Mar 8, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jan 9, 2023 | Jan 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 19, 2022 | Dec 16, 2022 |
| 8-K |
Current report
Other events
|
Dec 13, 2022 | Dec 13, 2022 |
| 8-K |
Current report
Other events
|
Nov 29, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2022 | Oct 24, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2022 | Sep 1, 2022 |
| 8-K |
Current report
Other events
|
Aug 10, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jun 6, 2022 | Jun 2, 2022 |
| 8-K |
Current report
Other events
|
May 23, 2022 | May 20, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2022 | Mar 9, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 11, 2022 | Jan 11, 2022 |
| 8-K |
Current report
Acquisition or sale of assets
|
Dec 22, 2021 | Dec 22, 2021 |
| 8-K |
Current report
Material agreement
|
Nov 19, 2021 | Nov 16, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 29, 2021 | Sep 28, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 20, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jun 9, 2021 | Jun 4, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Other events
|
Mar 29, 2021 | Mar 29, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2021 | Mar 9, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Other events
|
Dec 15, 2020 | Dec 14, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 10, 2020 | Dec 8, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2020 | Jun 11, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2020 | Mar 12, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 14, 2020 | Jan 10, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 27, 2019 | Dec 24, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2019 | Nov 6, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 28, 2019 | Aug 28, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 25, 2019 | Jul 22, 2019 |
Showing 88 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIRM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1759425
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.